Merck Receives Positive EU CHMP Opinion For Keytruda® (Pembrolizumab) Plus Padcev® (Enfortumab Vedotin-Ejfv)

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.